KRISTEEN KAGAL: Open Payments
NPI 1063663946 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 43 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $1,606 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $205 |
| BIOTRONIK NRO, Inc. | 6 | $164 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $156 |
| Medtronic, Inc. | 3 | $86 |
| Collegium Pharmaceutical, Inc. | 5 | $81 |
| Azurity Pharmaceuticals, Inc. | 3 | $55 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
Products named: Prospera, RELISTOR, QULIPTA, UBRELVY, INTELLIS ADAPTIVESTIM, XTAMPZA, HORIZANT, BOTOX.
Industry payments across TX — which companies pay providers there.
